RE: StemPrint23 May 2020 17:08
J427
You have a point. The company need to make sure that Tils also has some oomph left on its side. And not just move out the jewel. However others have written about it and although I’ve not heard the interview yet, folks have said that Tils have 4 major upsells and StemprintER isn’t what the company think is the best one. They have drugs too. So if the SP reached £2 hypothetically and then the split causes the Tils SP to re-rate at £1, you would still get the shares in Newco. So it’s not a lose lose scenario. These are random made up numbers.
That’s how I see it anyway. But yes absolutely there is no such thing as a free lunch and Tils won’t have the shareholders interests at heart primarily, it will be their own.
One thing I’m going to throw out there, Gabrielle bought shares at over £2 I read somewhere. Presently that looks like a dumb move. But nobody is stupid enough to throw money away. He must see prospects in this venture.